Tropical medicine & international health : TM & IH · 2005
Seroprevalence of Q-fever in febrile individuals in Mali.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Steinmann P, Bonfoh B, Péter O, Schelling E, Traoré M, Zinsstag J
Аннотация
OBJECTIVES: We conducted a serological survey for Q-fever among febrile patients in Bamako and Mopti (Mali) and investigated the main risk factors for seroconversion.
METHODS: Blood samples from 156 febrile patients were collected in healthcare facilities of Bamako and Mopti and examined with the microimmunofluorescence test.
RESULTS: Forty per cent (n = 63) were seropositive for Q-fever, 28% in Bamako and 51% in Mopti. A more recent infection was suspected in 9.5% (n = 6) of all seropositive patients. This is the first time that Q-fever seropositivity is reported in febrile individuals in Mali. The patients' symptoms and diagnoses spanned a wide range of conditions; none had been diagnosed with Q fever by their treating physician. No risk factors for seropositivity could be identified with the exception of the city of residence and none could be identified with a logistic regression model with 'city' taken as random effect.
CONCLUSION: A high rate of seropositivity to C. burnetii was found among febrile urban patients in Mali but no risk factors for seropositivity could be identified in this study.
METHODS: Blood samples from 156 febrile patients were collected in healthcare facilities of Bamako and Mopti and examined with the microimmunofluorescence test.
RESULTS: Forty per cent (n = 63) were seropositive for Q-fever, 28% in Bamako and 51% in Mopti. A more recent infection was suspected in 9.5% (n = 6) of all seropositive patients. This is the first time that Q-fever seropositivity is reported in febrile individuals in Mali. The patients' symptoms and diagnoses spanned a wide range of conditions; none had been diagnosed with Q fever by their treating physician. No risk factors for seropositivity could be identified with the exception of the city of residence and none could be identified with a logistic regression model with 'city' taken as random effect.
CONCLUSION: A high rate of seropositivity to C. burnetii was found among febrile urban patients in Mali but no risk factors for seropositivity could be identified in this study.